Analysis of Urinary Nucleosides

作者: Thomas D. McClure , Karl H. Schram

DOI: 10.1007/978-1-4899-1748-5_5

关键词:

摘要: Conventional diagnosis, disease staging, and evaluation of therapy for cancer acquired immune deficiency syndrome (AIDS) rely heavily on clinically observable measurements rather than biochemical tests. In the case cancer, these include tumor imaging tissue biopsy are accurate only after many cells have been produced as a consequence progression. A diagnosis AIDS is established by detection host-produced antibodies to human immunodeficiency virus (HIV), whereas measurement response therapy, determining type severity opportunistic infections (OI) suffered patients determined T- CD-4 cell populations (1). For both AIDS, methods can be unreliable; also, in some instances, they painful increase risk patient. example, mesothelioma (cancer pleural covering lung, most often result exposure asbestos fiber) an invasive procedure requiring rib resection obtain cytological analysis. dangerous level unreliability detecting HIV infection has observed results long lead time between production antibodies. recent study (2), were shown infected with 35 months before detected. As deficiencies clinical test methods, considerable research effort expended toward finding alternative indicators or “biomarkers” AIDS.

参考文章(83)
T. Rasmuson, G. R. Björk, L. Damber, S. E. Holm, L. Jacobsson, A. Jeppsson, B. Littbrand, T. Stigbrand, G. Westman, Evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase, and modified nucleosides as biological markers in malignant lymphomas. Recent results in cancer research. ,vol. 84, pp. 331- 343 ,(1983) , 10.1007/978-3-642-81947-6_25
J. Müller, N. Erb, G. Heller-Schöch, H. Lorenz, K. Winkler, G. Schöch, Multivariate analysis of urinary RNA catabolites in malignancies: cross-sectional and longitudinal studies. Recent results in cancer research. ,vol. 84, pp. 317- 330 ,(1983) , 10.1007/978-3-642-81947-6_24
C. W. Gehrke, R. W. Zumwalt, R. A. McCune, K. C. Kuo, Quantitative high-performance liquid chromatography analysis of modified nucleosides in physiological fluids, tRNA, and DNA. Recent results in cancer research. ,vol. 84, pp. 344- 359 ,(1983) , 10.1007/978-3-642-81947-6_26
E. Borek, O. K. Sharma, T. P. Waalkes, New applications of urinary nucleoside markers. Recent results in cancer research. ,vol. 84, pp. 301- 316 ,(1983) , 10.1007/978-3-642-81947-6_23
K. Randerath, H. P. Agrawal, E. Randerath, tRNA alterations in cancer. Recent results in cancer research. ,vol. 84, pp. 103- 120 ,(1983) , 10.1007/978-3-642-81947-6_7
Ernest Borek, Sylvia J. Kerr, Atypical transfer RNA's and their origin in neoplastic cells. Advances in Cancer Research. ,vol. 15, pp. 163- 190 ,(1972) , 10.1016/S0065-230X(08)60374-7
Thomas Dale. McClure, Biomedical applications of mass spectrometry. The University of Arizona.. ,(1991)
James A. McCloskey, [41] Constituents of nucleic acids: Overview and strategy Mass Spectrometry. ,vol. 193, pp. 771- 781 ,(1990) , 10.1016/0076-6879(90)93449-U